Category: Biomarkers
Global Biomarkers
-
Global Minimally Invasive Biopsy Techniques Market Assessment, By Product Offered [Tests, Kits & Consumables, Instruments], By Technique [Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others], By Circulating Biomarker [Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others], By Application [Clinical, Therapeutic], By End-user [Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Centres], By Region, Opportunities and Forecast, 2016-2030F
... Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others], By Application [Clinical, Therapeutic], By End-user [Hospitals & Clinics, Academic & Research Institutions, Ambulatory Care Centres], By Region, Opportunities and Forecast, 2016-2030F Global Minimally Invasive ... Read More
-
Clinical Diagnostics: Global Markets
... market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding clinical diagnostics. An in-depth market analysis includes historical data and market projections on sales by type of test, product type, ... Read More
-
2023 World Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in 98 Countries - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new 90-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well ... Read More
-
2023 Global Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities in tne USA, Europe, Japan - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - 2022 Competitive Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines ... Read More
-
Protein Purification and Isolation Market Forecasts to 2028 – Global Analysis By Product (Instruments and Consumables), Technology (Ultrafiltration, Precipitation, Preparative Chromatography, Electrophoresis, Western Blotting, Dialysis & Diafiltration and Centrifugation), Application (Biomarker Discovery, Disease Diagnostics & Monitoring, Drug Screening and Other Applications), End User and By Geography
... Monitoring, Drug Screening and Other Applications), End User and By Geography According to Stratistics MRC, the Global Protein Purification and Isolation Market is accounted for $8.24 billion in 2022 and is expected to reach $17.40 ... Read More
-
Cancer Biomarkers Market Forecasts to 2028 – Global Analysis By Cancer Type (Melanoma, Bladder Cancer and Other Cancer Types), Product (Software, Consumables and Other Products), Profiling Technologies (Immunoassay, Omics Technologies and Other Profiling Technologies), Application (Prognostics, Diagnostics and Other Applications), Biomarkers Type, Service and By Geography
... (Prognostics, Diagnostics and Other Applications), Biomarkers Type, Service and By Geography According to Stratistics MRC, the Global Cancer Biomarkers Market is accounted for $14.70 billion in 2022 and is expected to reach $40.92 billion by ... Read More
-
Renal Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 2.0 Billion by 2028, exhibiting a growth rate (CAGR) of 7.8% during 2023-2028. Renal biomarkers are cells, proteins, lipids, microRNAs, genes, metabolites, or proteomic patterns present on a urinalysis. They assist in determining the glomerular ... Read More
-
Global Cardiac Biomarkers Market to 2030
... 2022 to 2030 which makes the report an invaluable resource for business leaders, decision-makers, consultants, analysts, and other people looking for key industry data in a readily accessible document with clearly presented format. The report ... Read More
-
Next-Generation Breast Cancer Diagnostic and Screening Market - A Global Market and Regional Analysis: Focus on Technology, Cancer Sub-Type, Biomarker, Offering, End User, and Country Analysis - Analysis and Forecast, 2023-2032
... Diagnostic and Screening Market: Industry Overview The global next-generation breast cancer diagnostic and screening market was valued at $3,137.4 million in 2022 and is anticipated to reach $9,880.1 million by 2032, witnessing a CAGR of ... Read More
-
Immuno-Oncology (IO) - Thematic Intelligence
... - major current and future players in the immuno-oncology field. The field of immuno-oncology (IO) is consolidating its presence in most major types of cancer. Checkpoint modulation to remain the most valuable IO sector. 2022–23 ... Read More
-
Global Central Nervous System Biomarkers Market Size study & Forecast, by Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Others) by Application (Drug Discovery and Development, Personalized Medicine, Other Applications), by End User (Diagnostic Labs, Clinics/Hospitals, Research Centers) and Regional Analysis, 2022-2029
... Research Centers) and Regional Analysis, 2022-2029 Global Central Nervous System Biomarkers Market is valued approximately at USD 4.19 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.00% ... Read More
-
Global Renal Biomarkers Market Size study & Forecast, by Biomarker type (Functional Biomarker, Up-regulated Protein, and Other Biomarker Types) by Diagnostic Technique ((Enzyme-linked Immunosorbent Assay, Particle-enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), and Liquid Chromatography-mass Spectrometry (LS-MS)), by End User (Hospitals, Diagnostic Laboratories, and Other End Users) and Regional Analysis, 2022-2029
... and Liquid Chromatography-mass Spectrometry (LS-MS)), by End User (Hospitals, Diagnostic Laboratories, and Other End Users) and Regional Analysis, 2022-2029 Global Renal Biomarkers Market is valued at approximately USD XX billion in 2021 and is anticipated ... Read More
-
Global Next Generation Cancer Diagnostic Market Size study & Forecast, by Technology ( Next-Generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays) by Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), by Function(Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis) and Regional Analysis, 2022-2029
... Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), by Function(Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis) and Regional Analysis, 2022-2029 Global Next ... Read More
-
Top 10 Medical Device Technologies Market by Type (In Vitro Diagnostics, Diagnostics Imaging, Orthopedic, Ophthalmology, Cardiology, Endoscopy, Diabetes Care, Respiratory Care & Anesthesia, Kidney/Dialysis Devices) and Region - Global Forecast to 2027
... 10 Medical Device Technologies market is projected to reach USD 577.5 billion by 2027 from USD 437.4 billion in 2022, at a CAGR of 5.7% during the forecast period. Globally, with the rapid growth in ... Read More
-
Genomics Market by Product & Service (Consumables, Instrument, System & Software), Technology (Sequencing, PCR, Microarray), Study Type (Epigenomics, Biomarker Discovery), Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2028
... projected to reach USD 83.1 billion by 2028 from USD 46.2 billion in 2023, at a CAGR of 12.4% during the forecast period of 2023 to 2028. . Continuous developments in sequencing technologies and a ... Read More
-
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
... product analyses within disease subsegments to overall industry trends, in order to quantify and qualify the global CNS biomarkers market. Current and projected product forecasts during the forecast period (2022 to 2027) are discussed. New ... Read More
-
Global Cell-Based Assay Market - A Global and Regional Analysis: Focus on Product, Services, Application, End User, Technology, Regional Analysis, and Competitive Landscape - Analysis and Forecast, 2023-2032
... global cell-based assay market is expected to reach $38.23 billion in 2032 from $17.20 billion in 2022, at a CAGR of 8.44% during the forecast period 2023-2032. Market Lifecycle Stage The global cell-based assay market ... Read More
-
Multicancer Screening Market - A Global and Regional Analysis: Focus on Test Type, Technology, Sample, Method, Cancer Type, Application, End User, and Region Analysis - Analysis and Forecast, 2023-2032
... The global multicancer screening market is projected to reach $7.78 billion by 2032 from $1.90 billion in 2022, growing at a CAGR of 15.09% during the forecast period 2023-2032. The growth in the global multicancer ... Read More
-
Global Acute Myeloid Leukemia Biomarker Detection Market Growth 2023-2029
... to grow at a CAGR of % from 2023 to 2029. United States market for Acute Myeloid Leukemia Biomarker Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at ... Read More
-
Patient Derived Xenograft Models Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... pandemic, cancer research was halted as the majority of studies were focused on developing drugs for COVID-19. However, post-pandemic, the majority of the focus of researchers has been on developing innovative therapies for cancer. This ... Read More
-
Global Artificial Intelligence (AI) in Healthcare Market 2022-2028
... learning and deep learning technology used by many sectors including remote sensing, medical diagnosis, electronic trading, transportation, education, and others. It is one of the essential tools in the healthcare industry as it supports analyzing ... Read More
-
2023 Global Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Europe, Japan - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The ... Read More
-
2023 Global Forecast for Exosome Diagnostic And Therapeutic Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. Published annually, this report provides a unique and accurate ... Read More
-
Real-World Evidence, Social Determinants of Health, and Digital Biomarkers in Driving Patient Recruitment
... using RWD, leveraging SDoH to drive diversity and equity in clinical trials, and the significant potential of digital biomarkers in driving patient recruitment. It reviews the factors that need to be taken into consideration when ... Read More
-
Biomarkers Market by Product & Service (Consumable, Service, Software), Type (Safety, Efficacy, Validation), Disease (Cancer, Infectious, Neurological), Application (Diagnostics, Drug Discovery, Personalized Medicine), Region - Global Forecast to 2028
... to reach USD 104.0 billion in 2028 from USD 59.1 billion in 2023 at a CARG of 12.0%. Factors responsible for the growth in the biomarkers market are mainly factors such as the growing importance ... Read More
Research Assistance
